EUROGIN 2026 – International Multidisciplinary HPV Congress

Don’t miss these Scientific Sessions:

• SS 07 - "Developments and Standardization of methylation tests in cervical, anal and urine samples" on Wednesday at 17:00
• FC 23 - "Methylation II session" on Saturday at 09:40, where our full automated workflow for methylation testing will be presented. 

 
Methylation testing is gaining interest and scientific evidence is growing to support clinical use to improve risk stratification and management of HPV-related precursor cervical, vulva or anal lesions. 

This is reflected in the many methylation-related topics at the EUROGIN 2026 conference. Just a few picks:

• Wednesday 18, Hall N2 10.30-12.00, FC 04 • MOLECULAR BIOLOGY I:
  De Marco L., “Assessment of the prevalence of HPV infection and anal cytological abnormalities in patients with HPV-related lower genital tract lesions (cervix, vagina and vulva)”
• Thursday 19, Hall N2 17.30 • 19.00, HN 05 • SUBMITTED PAPERS II:
  Njoku R. C., “Methylation biomarkers in liquid biopsies of patients with HPV-related oropharyngeal squamous cell carcinomas”
• Friday 20, Room 1.85/1.86 18.00 • 19.30, FC 21 • SELF-SAMPLING II:
  Viti J., “Acceptability of self-sampling for hrHPV DNA testing in cervical cancer screening in Florence”
• Saturday 21, Hall N2, FC 23 9.40 • 11.00 • METHYLATION II:
  Alfedi G., “Advanced HPV screening and triage: A full molecular workflow with automation and self-sampling”

... and many more!

Automated workflow is crucial for implementation in clinical labs. Fujirebio is taking this next step, preparing for the promising future of methylation testing.

Looking forward to seeing you in Vienna!